• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在马拉维引入“B 方案+”项目之前和之后出生的 HIV 暴露但未感染儿童的体重增加。

Weight gain of HIV-exposed, uninfected children born before and after introduction of the 'Option B+' programme in Malawi.

机构信息

Institute of Global Health, University of Geneva, Geneva, Switzerland.

Baobab Health Trust, Lilongwe, Malawi.

出版信息

AIDS. 2018 Sep 24;32(15):2201-2208. doi: 10.1097/QAD.0000000000001942.

DOI:10.1097/QAD.0000000000001942
PMID:30005013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6136966/
Abstract

OBJECTIVE

To compare birth weight and weight gain in HIV-exposed, uninfected (HEU) infants up to 24 months old, who enrolled in the Malawian national HIV care clinic (HCC) programme either before or after Option B+ (OB+) was implemented.

DESIGN, SETTING AND PARTICIPANTS: HIV-exposed infants enrol in the HCC programme as soon as possible after birth and are followed up to at least 24 months old. This analysis includes HEU infants with recorded birth weight, date of birth, gender and at least one follow-up weight measurement from 21 health facilities in central and southern Malawi (January 2010-December 2014). Weight-for-age z scores (WAZ) were derived and compared by birth period using linear regression at birth and mixed effects models for postnatal weight gain up to 24 months old.

RESULTS

Of 6845 HEU infants included in this study, 88.5% were born after OB+. The proportion of infants exposed in utero to combination antiretroviral therapy (ART) significantly increased after OB+ was implemented, and infants were exposed to ART for a longer time. There was no significant difference in WAZ at birth (P = 0.654) among HEU infants by birth period, but postnatal weight gain was faster among HEU infants born in the Option B+ period than infants born pre-Option B+.

CONCLUSION

Birth weight was not affected by longer exposure to ART during pregnancy after OB+ was introduced, when weight gain in HEU infants was faster, possibly because their mothers were in better health.

摘要

目的

比较在马拉维国家艾滋病毒护理诊所(HCC)方案中登记的、在实施选项 B+(OB+)之前或之后的 HIV 暴露但未感染(HEU)婴儿在 24 个月龄时的出生体重和体重增加情况。

设计、地点和参与者:HIV 暴露婴儿在出生后尽快登记到 HCC 方案中,并至少随访至 24 个月龄。本分析包括在马拉维中部和南部的 21 个卫生机构中,有记录的出生体重、出生日期、性别和至少一次随访体重测量值的 HEU 婴儿(2010 年 1 月至 2014 年 12 月)。通过线性回归在出生时获得体重与年龄比值(WAZ)并进行比较,在出生后通过混合效应模型比较在 24 个月龄时的体重增加情况。

结果

本研究纳入的 6845 名 HEU 婴儿中,88.5%是在 OB+后出生的。OB+实施后,胎儿暴露于联合抗逆转录病毒疗法(ART)的婴儿比例显著增加,且婴儿暴露于 ART 的时间更长。但根据出生时期,HEU 婴儿的 WAZ 在出生时无显著差异(P=0.654),但在 OB+后出生的 HEU 婴儿的体重增加速度比 OB+前出生的婴儿快。

结论

OB+实施后,当 HEU 婴儿的体重增加更快时,出生体重并未受到妊娠期间更长时间暴露于 ART 的影响,这可能是因为其母亲的健康状况更好。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a2/6136966/7b009c2ad1e6/nihms-980341-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a2/6136966/3ff315316979/nihms-980341-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a2/6136966/7b009c2ad1e6/nihms-980341-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a2/6136966/3ff315316979/nihms-980341-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/67a2/6136966/7b009c2ad1e6/nihms-980341-f0002.jpg

相似文献

1
Weight gain of HIV-exposed, uninfected children born before and after introduction of the 'Option B+' programme in Malawi.在马拉维引入“B 方案+”项目之前和之后出生的 HIV 暴露但未感染儿童的体重增加。
AIDS. 2018 Sep 24;32(15):2201-2208. doi: 10.1097/QAD.0000000000001942.
2
Growth trajectories of breastfed HIV-exposed uninfected and HIV-unexposed children under conditions of universal maternal antiretroviral therapy: a prospective study.在普遍使用母婴抗逆转录病毒疗法的条件下,母乳喂养的 HIV 暴露但未感染和未暴露于 HIV 的儿童的生长轨迹:一项前瞻性研究。
Lancet Child Adolesc Health. 2019 Apr;3(4):234-244. doi: 10.1016/S2352-4642(19)30007-0. Epub 2019 Feb 15.
3
In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.子宫内暴露于抗逆转录病毒药物:对巴西HIV暴露未感染儿童出生体重和生长的影响。
Pediatr Infect Dis J. 2016 Jan;35(1):71-7. doi: 10.1097/INF.0000000000000926.
4
Lower birth weight-for-age and length-for-age z-scores in infants with in-utero HIV and ART exposure: a prospective study in Cape Town, South Africa.在南非开普敦进行的一项前瞻性研究显示,在宫内 HIV 暴露和接受抗逆转录病毒治疗(ART)的婴儿中,体重与年龄和身长与年龄的 Z 评分较低。
BMC Pregnancy Childbirth. 2021 May 4;21(1):354. doi: 10.1186/s12884-021-03836-z.
5
Children Exposed or Unexposed to Human Immunodeficiency Virus: Weight, Height, and Body Mass Index During the First 5 Years of Life-A Danish Nationwide Cohort.儿童接触或未接触人类免疫缺陷病毒:生命最初 5 年的体重、身高和身体质量指数-丹麦全国队列研究。
Clin Infect Dis. 2020 May 6;70(10):2168-2177. doi: 10.1093/cid/ciz605.
6
Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration.南非暴露于HIV但未感染婴儿出生后前6个月的生长发育情况:IeDEA-SA合作项目
PLoS One. 2016 Apr 6;11(4):e0151762. doi: 10.1371/journal.pone.0151762. eCollection 2016.
7
In utero antiretroviral exposure and sociodemographic characteristics on neurodevelopment of HIV-exposed uninfected children versus HIV-unexposed uninfected healthy children in Malawi.在马拉维,子宫内抗逆转录病毒暴露和社会人口特征对 HIV 暴露但未感染的儿童与 HIV 未暴露但未感染的健康儿童的神经发育的影响。
Int J Gynaecol Obstet. 2021 Jun;153(3):424-437. doi: 10.1002/ijgo.13511. Epub 2020 Dec 31.
8
Growth Faltering and Developmental Delay in HIV-Exposed Uninfected Ugandan Infants: A Prospective Cohort Study.HIV 暴露但未感染的乌干达婴儿生长发育迟缓及发育迟缓:一项前瞻性队列研究。
J Acquir Immune Defic Syndr. 2021 May 1;87(1):730-740. doi: 10.1097/QAI.0000000000002626.
9
Maternal breastfeeding and education impact infant growth and development more than in-utero HIV/antiretroviral therapy exposure in context of universal antiretroviral therapy.在普遍应用抗逆转录病毒疗法的背景下,与宫内 HIV/抗逆转录病毒治疗暴露相比,产妇母乳喂养和教育对婴儿的生长发育影响更大。
AIDS. 2024 Mar 15;38(4):537-546. doi: 10.1097/QAD.0000000000003785. Epub 2023 Nov 14.
10
Associations Between Dietary Intake Before 6 Months of Age and Rapid Weight Gain Among HIV-exposed Uninfected Infants.6个月龄前的饮食摄入与HIV暴露未感染婴儿快速体重增加之间的关联
J Pediatr Gastroenterol Nutr. 2017 Nov;65(5):e104-e109. doi: 10.1097/MPG.0000000000001607.

引用本文的文献

1
Clinical and immunological outcomes of HIV-exposed uninfected and HIV-unexposed uninfected children in the first 24 months of life in Western Kenya.在肯尼亚西部,HIV 暴露但未感染和未暴露 HIV 的儿童在生命的头 24 个月的临床和免疫结果。
BMC Infect Dis. 2024 Feb 1;24(1):156. doi: 10.1186/s12879-024-09051-3.
2
Clinical and programmatic outcomes of HIV-exposed infants enrolled in care at geographically diverse clinics, 1997-2021: A cohort study.1997-2021 年在地理分布不同的诊所接受治疗的 HIV 暴露婴儿的临床和项目结局:一项队列研究。
PLoS Med. 2022 Sep 15;19(9):e1004089. doi: 10.1371/journal.pmed.1004089. eCollection 2022 Sep.
3

本文引用的文献

1
HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.马拉维预防母婴传播项目中HIV暴露儿童的HIV传播及护理留存情况
J Int AIDS Soc. 2017 Sep 4;20(1):21947. doi: 10.7448/IAS.20.1.21947.
2
Growth of HIV-exposed uninfected, compared with HIV-unexposed, Zambian children: a longitudinal analysis from infancy to school age.与未接触过艾滋病毒的赞比亚儿童相比,接触过艾滋病毒但未感染儿童的生长情况:一项从婴儿期到学龄期的纵向分析。
BMC Pediatr. 2017 Mar 16;17(1):80. doi: 10.1186/s12887-017-0828-6.
3
Option B+ for prevention of vertical HIV transmission has no influence on adverse birth outcomes in a cross-sectional cohort in Western Uganda.
Growth patterns of infants with in- utero HIV and ARV exposure in Cape Town, South Africa and Lusaka, Zambia.
南非开普敦和赞比亚卢萨卡宫内 HIV 和 ARV 暴露婴儿的生长模式。
BMC Public Health. 2022 Jan 10;22(1):55. doi: 10.1186/s12889-021-12476-z.
4
Contemporary Issues in Pregnancy (and Offspring) in the Current HIV Era.当前 HIV 时代妊娠(及其后代)的当代问题。
Curr HIV/AIDS Rep. 2019 Dec;16(6):492-500. doi: 10.1007/s11904-019-00465-2.
5
Timing of combination antiretroviral therapy (cART) initiation is not associated with stillbirth among HIV-infected pregnant women in Malawi.在马拉维,感染艾滋病毒的孕妇启动联合抗逆转录病毒疗法(cART)的时机与死产无关。
Trop Med Int Health. 2019 Jun;24(6):727-735. doi: 10.1111/tmi.13233. Epub 2019 Apr 1.
在乌干达西部的一个横断面队列研究中,预防艾滋病毒垂直传播的B+方案对不良分娩结局没有影响。
BMC Pregnancy Childbirth. 2017 Mar 7;17(1):82. doi: 10.1186/s12884-017-1263-2.
4
PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi.预防母婴传播方案B+不会增加早产风险,且可能预防极早产:马拉维的一项回顾性队列研究
J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):367-374. doi: 10.1097/QAI.0000000000001253.
5
Growth of HIV-Exposed Uninfected Infants in the First 6 Months of Life in South Africa: The IeDEA-SA Collaboration.南非暴露于HIV但未感染婴儿出生后前6个月的生长发育情况:IeDEA-SA合作项目
PLoS One. 2016 Apr 6;11(4):e0151762. doi: 10.1371/journal.pone.0151762. eCollection 2016.
6
Preterm Birth and Low Birth Weight after In Utero Exposure to Antiretrovirals Initiated during Pregnancy in Yaoundé, Cameroon.喀麦隆雅温得地区孕期开始宫内暴露于抗逆转录病毒药物后的早产和低出生体重情况。
PLoS One. 2016 Mar 21;11(3):e0150565. doi: 10.1371/journal.pone.0150565. eCollection 2016.
7
In Utero Exposure to Antiretroviral Drugs: Effect on Birth Weight and Growth Among HIV-exposed Uninfected Children in Brazil.子宫内暴露于抗逆转录病毒药物:对巴西HIV暴露未感染儿童出生体重和生长的影响。
Pediatr Infect Dis J. 2016 Jan;35(1):71-7. doi: 10.1097/INF.0000000000000926.
8
Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants.子宫内母婴 HIV 暴露和抗逆转录病毒暴露对 HIV 暴露婴儿的代谢并发症。
Pediatr Infect Dis J. 2014 Jul;33(7):734-40. doi: 10.1097/INF.0000000000000224.
9
Maternal HIV infection and other factors associated with growth outcomes of HIV-uninfected infants in Entebbe, Uganda.乌干达恩德培母婴 HIV 感染及其他因素与 HIV 未感染婴儿生长结局的关系。
Public Health Nutr. 2013 Sep;16(9):1548-57. doi: 10.1017/S1368980013000499. Epub 2013 Mar 18.
10
Effect of highly active antiretroviral treatment (HAART) during pregnancy on pregnancy outcomes: experiences from a PMTCT program in western India.孕期高效抗逆转录病毒治疗(HAART)对妊娠结局的影响:来自印度西部一个 PMTCT 项目的经验。
AIDS Patient Care STDS. 2013 Mar;27(3):163-70. doi: 10.1089/apc.2012.0401.